0001209191-20-063366.txt : 20201214
0001209191-20-063366.hdr.sgml : 20201214
20201214205800
ACCESSION NUMBER: 0001209191-20-063366
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201211
FILED AS OF DATE: 20201214
DATE AS OF CHANGE: 20201214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gonyer David A
CENTRAL INDEX KEY: 0001578768
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36075
FILM NUMBER: 201387948
MAIL ADDRESS:
STREET 1: C/O EVOKE PHARMA, INC.
STREET 2: 505 LOMAS SANTA FE DRIVE
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Evoke Pharma Inc
CENTRAL INDEX KEY: 0001403708
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208447886
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 420 STEVENS AVENUE
STREET 2: SUITE 370
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
BUSINESS PHONE: 858-345-1494
MAIL ADDRESS:
STREET 1: 420 STEVENS AVENUE
STREET 2: SUITE 370
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-11
0
0001403708
Evoke Pharma Inc
EVOK
0001578768
Gonyer David A
C/O EVOKE PHARMA, INC.
420 STEVENS AVENUE, SUITE 370
SOLANA BEACH
CA
92075
1
1
0
0
President and CEO
Common Stock
2020-12-11
4
S
0
48046
2.90
D
363736
D
Common Stock
2020-12-14
4
S
0
23954
2.94
D
339782
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.90 to $2.93. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and
Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in
this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.93 to $2.97. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Matthew J. D'Onofrio, Attorney-in-fact for David A. Gonyer
2020-12-14